The inverse relationship between INHBA and hsa-miR-375 in our study suggests that restoring the levels of hsa-miR-375 could potentially suppress INHBA activity, offering a therapeutic approach to inhibit tumor progression in colon cancer. The gene discussed is INHBA; the disease is colonic neoplasm.